Prisyna, a Claremont, Calif.-based oral care business unit of Synedgen, Inc., secured a $6m in funding.
The round was led by Andrew Miller.
The company intends to use the funds for advanced development, regulatory approval and marketing efforts for the expansion of its pipeline and in support of current products.
Led by co-founders William Wiesmann, M.D. and Shenda Baker, Ph.D., Prisyna combines propriety glycomics technology, with natural materials and innovative polysaccharides to create advanced rinses for the mouth that support a healthy oral cavity. The company’s investigational products include Moistagen®, a potential treatment for the symptoms of dry mouth, and a new formulation to relieve the symptoms of oral mucositis due to chemotherapy or radiation treatments.
The company currently offers two oral rinse products, Synedent® Oral Care and Synedent Plus Oral Care with fluoride.
FinSMEs
28/04/2016